Bibliographic Info
GuidelineUpdated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services.
Year of Publication2024
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended in favor
Conditional
Certainty of evidence
Low
For adults and adolescents (including pregnant women) with genital, anorectal and/or oropharyngeal gonococcal infections, WHO suggests:
- ceftriaxone 1 g intramuscularly as a single dose.
If ceftriaxone is not available or refused, WHO suggests:
- cefixime 800 mg orally and performing test of cure.
If test of cure is not possible or when oropharyngeal infection is diagnosed or is a potential concern, WHO suggests:
- cefixime 800 mg orally plus azithromycin 2 g orally.
When resistance, allergy or availability of cephalosporins is a concern, WHO suggests one of the following options:
- spectinomycin 2 g intramuscularly as a single dose plus azithromycin 2 g
orally; or
- gentamicin 240 mg intramuscularly as a single dose plus azithromycin 2 g orally